Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings

Hypertension

Volumn 27, Issue 6, 1996, Pages 1346-1352

  Ullian, Michael E ^a,b   Hazen Martin, Debra J ^a   Walsh, Lyle G ^a   Davda, Rajesh K ^a   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

angiotensin II; carbenoxolone; endothelium; muscle, smooth, vascular; receptors, adrenergic; vasoconstriction

Indexed keywords

CARBENOXOLONE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; DRUG EFFECT; ENZYME INHIBITION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0030026620     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.6.1346     Document Type: Article

References (32)

1. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242:583-585.
2. Funder JW, Pearce PT, Smith R, Camphell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology. 1989;125:2224-2226.
3. Walker BR, Yau JL, Brett LP. Seckl JR, Monde C. Williams BC, Edwards CRW. 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
4. Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension. 1984;6:236-241.
5. Grunfeld JP, Eloy L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension. 1987;10:608-618.
6. Yagil Y, Krakoff LR. The differential effect of aldosterone and dexamethasone on pressor responses in adrenalectomized rats. Hypertension. 1988;11:174-178.
7. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension. 1992;19:567-574.
8. Teelucksing S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CRW. Potentiation of hydrocortisone activity in skin by glycyrrhetinic. Lancet. 1990;335:1060-1063.
9. Walker BR, Connacher AA, Webb, DJ, Edwards CRW. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci. 1992;83:171-178.
10. Dembinska-Kiec A, Pallapies D, Simmet T, Peskar BM, Peskar BA. Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection. Br J Pharmacol. 1991;104:811-816.
11. Walker BR, Sang KS, Williams BC, Edwards CRW. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J Hypertens. 1994;12:33-39.
12. Todd ME, Friedman SM. The rat-tail artery maintained in culture: an experimental model. In Vitro. 1978;14:757-770.
13. Merrilees MJ, Scott L. Organ culture of rat carotid artery: maintenance of morphological characteristics and of pattern of matrix synthesis. In Vitro. 1982;18:900-910.
14. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension. 1991;18: 158-164.
15. Monder C. Corticosteroids, kidneys, sweet roots, and dirty drugs. Mol Cell Endocrinol. 1991;78:C95-C98.
16. Descamps C, Vandenbroucke JM, van Ypersele de Strihou C. Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment. Br Med J. 1977;1:277.
17. Hurley B. Acute renal failure associated with carbenoxolone treatment. Br Med J. 1977;1:1472.
18. Baron DN, Green RJ. Action of compounds with effective in vivo mineralocorticoid activity on ion transport in leucocytes. Br J Clin Pharmacol. 1986;21:27-34.
19. Symons AM, Johnston B, Parke D. The effect of sodium carbenoxolone on lysosomal enzyme release. Biochem Pharmacol. 1978; 27:2461-2463.
20. Symons AM. The effect of sodium carbenoxolone on the permeability of phosphatidylcholine and phosphatidylcholine:cholesterol liposomes. Biochem Pharmacol. 1976;25:1545-1547.
21. Porter GA, Rhodes C, Sacra P. Comparative studies on the mineralocorticoid action of aldosterone and carbenoxolone sodium in the adrenalectomized rat. Pharmacology. 1974;12:224-229.
22. Takeda R, Miyamori I, Soma R, Matsubara T, Ikeda M. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist. J Steroid Biochem. 1987;27:845-849.
23. Monder C, Steware PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 1989; 125:1046-1053.
24. Zhang J, van Meel JCA, Pfaffendorf M, Zhang J, van Zwieten PA. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur J Pharmacol. 1994;262:247-253.
25. Yoshida H, Tamaki T, Aki Y, Kimura S, Takenaka I, Abe Y. Effects of angiotensin II on isolated rabbit afferent arterioles. Jpn J Pharmacol. 1994;66:457-464.
26. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.
27. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
28. Pollack DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
29. Hatakeyama H, Miyamori I, Fujit T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosteronea biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269:24316-24320.
30. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Production of aldosterone in isolated rat blood vessels. Hypertension. 1994;25:170-173.
31. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology. 1994;135:2283-2286.
32. Parke DV. The pharmacology and biochemistry of carbenoxolone. In: Beck IT, ed. North American Symposium on Carbenoxolone. New York, NY: American Elsevier Publishing Co, Inc, Excerpta Medical; 1976.